ABVC BioPharma Provides 2023 Pipeline Update
28. Februar 2023 08:30 ET
|
ABVC BioPharma, Inc.
FREMONT, CA, Feb. 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...
ABVC BioPharma Announces Vitargus® Phase II Study Plan Approved by HREC in Australia
05. Oktober 2022 08:30 ET
|
ABVC BioPharma, Inc.
FREMONT, CA, Oct. 05, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC Biopharma, Inc. (NASDAQ: ABVC), a clinical-stage biopharmaceutical company developing therapeutic solutions in...
ABVC BioPharma Provides Vitargus® Update
18. August 2022 08:30 ET
|
ABVC BioPharma, Inc.
Phase II Vitargus® Clinical Trial Receives Local Ethics Committee Approval in Thailand FREMONT, CA, Aug. 18, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a...
ABVC BioPharma Provides Vitargus® Update
02. August 2022 08:30 ET
|
ABVC BioPharma, Inc.
Phase II Vitargus® Clinical Study Protocol Receives Local Ethics Committee Approval FREMONT, CA, Aug. 02, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a...
ABVC BioPharma Provides Vitargus® Update
30. Juni 2022 08:30 ET
|
ABVC BioPharma, Inc.
Vitargus® Receives Phase II Thailand Central Research Ethics Committee Approval FREMONT, CA, June 30, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a...
ABVC BioPharma Provides Vitargus® Update
26. August 2021 08:30 ET
|
ABVC BioPharma, Inc.
FREMONT, CA, Aug. 26, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC), a clinical stage biopharmaceutical company developing therapeutic solutions in...
American BriVision Provides Corporate Update
28. Februar 2020 09:00 ET
|
American BriVision Holding Corporation
FREMONT, CA, Feb. 28, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- American BriVision (Holding) Corporation (OTCQB: ABVC), an emerging clinical stage biopharmaceutical company focused on...
American BriVision Announces Postponement of Proposed Public Offering
25. Februar 2020 12:57 ET
|
American BriVision Holding Corporation
Company Expects to Begin Licensing Vitargus to Marketing Partners in 2020 FREMONT, CA, Feb. 25, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- American BriVision (Holding) Corporation (OTCQB:...